Bioethics News

FDA Approves Hormonal Contraception Device to Give Women Greater Choice

(The Guardian) – The US Food and Drug Administration (FDA) approved a hormonal device on Friday that gives American women another reversible contraceptive choice as effective as sterilization. The intrauterine device (IUD) device, Liletta, releases the hormone levonorgestrel to inhibit thickening of the womb lining, preventing pregnancy for up to three years.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.